SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs - Quaterly Results

02 Nov 2023 Evaluate
The September 2023 quarter revenue stood at Rs. 267.60 millions, up 20.94% as compared to Rs. 221.27 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2023 is Rs. -2.92 millions as compared to Net Loss of Rs. -3.96 millions of corresponding quarter ended September 2022The Operating Profit of the company witnessed a decrease to 42.40 millions from 57.70 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 267.60 221.27 20.94 479.97 440.05 9.07 805.93 1643.49 -50.96
Other Income 3.04 10.39 -70.74 7.32 17.23 -57.52 34.52 27.20 26.91
PBIDT 42.40 57.70 -26.52 72.25 123.74 -41.61 190.52 1002.19 -80.99
Interest 11.71 29.14 -59.81 25.04 57.15 -56.19 115.70 199.21 -41.92
PBDT 30.24 27.19 11.22 46.76 65.21 -28.29 3.08 756.30 -99.59
Depreciation 34.63 34.55 0.23 67.98 68.69 -1.03 135.16 153.89 -12.17
PBT -4.39 -7.36 -40.35 -21.22 -3.48 509.77 -132.08 602.41 -121.93
TAX -1.47 -3.40 -56.76 -1.10 -2.79 -60.57 0.78 203.38 -99.62
Deferred Tax -2.47 -3.40 -27.35 -4.45 -2.79 59.50 -1.29 203.38 -100.63
PAT -2.92 -3.96 -26.26 -20.12 -0.69 2815.94 -132.86 399.03 -133.30
Equity 330.90 286.90 15.34 330.90 286.90 15.34 306.90 286.90 6.97
PBIDTM(%) 15.84 26.08 -39.24 15.05 28.12 -46.47 23.64 60.98 -61.23

Lyka Labs Share Price

65.10 3.10 (5.00%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×